Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical StudiesSarah‐Eve Lemay, Sébastien Bonnet, Keiko Yamamoto et al.|Circulation|2025Cited by 26
Abstract 4139465: Integrin α5β1 represents a novel therapeutic target to improve vascular remodeling in pulmonary arterial hypertensionSarah‐Eve Lemay, Sébastien Bonnet, Mónica S. Montesinos et al.|Circulation|2024Cited by 1
Implication of Integrin α5β1 in right ventricular failure associated with pulmonary arterial hypertensionSarah‐Eve Lemay, Sébastien Bonnet, Mónica S. Montesinos et al.|Unknown|2024Cited by 0
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical StudiesSarah‐Eve Lemay, Sébastien Bonnet, Mónica S. Montesinos et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0
Abstract 4139456: Integrin α5β1 contributes to pathological remodeling of the right ventricle in pulmonary arterial hypertensionSarah‐Eve Lemay, Sébastien Bonnet, Mónica S. Montesinos et al.|Circulation|2024Cited by 0